Background
Researchers, cancer registry staff, and others use U.S. Cancer Statistics data to advance scientific knowledge and reduce cancer. Stat Bites, data briefs, and a selection of peer-reviewed journal articles that use U.S. Cancer Statistics data are highlighted below.
Stat Bites
In the U.S. in 2021, 209,500 new lung cancers were reported.
In the United States in 2021, 141,902 new colorectal cancers were reported.
In the United States in 2021, 236,659 new prostate cancers were reported.
In the United States in 2021, 272,454 new breast cancers were reported in females.
Data briefs
U.S. Cancer Statistics includes 1,777,566 new cases of invasive cancer occurring in 2021.
During 2001 to 2020, 161,969 cases of testicular cancer were reported in the United States.
The most common gastrointestinal cancers were colorectal, esophagus, liver, pancreas, and stomach.
In 2019, 224,733 new cases of prostate cancer were reported in the United States.
In 2019, 142,462 cases of colon and rectum cancer were reported in the United States.
Cancer rates increased from 1999 to 2019 in American Indian and Alaska Native people ages 15 to 39.
About 47,000 HPV-associated cancers occurred in the United States each year from 2015 to 2019.
Describes incidence, survival, and prevalence rates for leukemias, lymphomas, and myeloma.
Selected journal articles
2024
- Campbell K, Siegel DA, Umaretiya PJ, et al. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatr Blood Cancer. 2024;71(1):e30732.
- Gopalani SV, Senkomago V, Rim SH, Saraiya M. Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates—United States, 2001–2019. J Natl Cancer Inst. 2024;116(2):275–282.
2023
- Holman DM, King JB, White A, Singh SD, Lichtenfeld JL. Acral lentiginous melanoma incidence by sex, race, ethnicity, and stage in the United States, 2010–2019. Prev Med. 2023:175:107692.
- Siegel DA, King JB, Lupo PJ, et al. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003–2019. J Natl Cancer Inst. 2023;115(11):1337–1354.
2022
- Chang SH, Patel N, Du M, Liang PS. Trends in early-onset vs. late-onset colorectal cancer incidence by race/ethnicity in the United States Cancer Statistics database. Clin Gastroenterol Hepatol. 2022;20(6):e1365–e1377.
- Cho MY, Siegel DA, Demb J, Richardson LC, Gupta S. Increasing colorectal cancer incidence before and after age 50: implications for screening initiation and promotion of "on-time" screening. Dig Dis Sci. 2022;67(8):4086–4091.
- Ellington TD, Miller JW, Henley SJ, Wilson RJ, Wu, M, Richardson LC. Trends in breast cancer incidence, by race, ethnicity, and age among women aged ≥ 20 years—United States, 1999–2018. MMWR Morb Mortal Wkly Rep. 2022;71(2):43.
- Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. Trends in human papillomavirus–associated cancers, demographic characteristics, and vaccinations in the US, 2001–2017. JAMA Netw Open. 2022;5(3):e222530.
- Melkonian SC, Jim MA, Pete D, et al. Cancer disparities among non-Hispanic urban American Indian and Alaska Native populations in the United States, 1999–2017. Cancer. 2022;128(8):1626–1636.
- Minihan AK, Patel AV, Flanders WD, Goding Sauer A, Jemal A, Islami F. Proportion of cancer cases attributable to physical inactivity by US state, 2013–2016. Med Sci Sports Exerc. 2022;54(3):417–423.
- Raza SA, da Costa WL, Thrift AP. Increasing incidence of gallbladder cancer among non-Hispanic Blacks in the United States: a birth cohort phenomenon. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1410–1417.
- Shah RR, Millien VO, da Costa WL, Oluyomi AO, Gould Suarez M, Thrift AP. Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017. Cancer. 2022;128(2):299–310.
2021
- Bartley SJ, Wu M, Benard V, Ambrosone C, Richardson LC. Are there regional differences in triple negative breast cancer among non-Hispanic Black women? J Natl Med Assoc. 2021;113(3):353–356.
- Culp MB, Benard V, Dowling NF, et al. Ocular melanoma incidence rates and trends in the United States, 2001–2016. Eye (Lond). 2021;35(2):687–689.
- Ellington TD, Henley SJ, Wilson RJ, Wu M, Richardson LC. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003–2016. Cancer Med. 2021;10(1):386–395.
- Mix JM, Van Dyne EA, Saraiya M, Hallowell BD, Thomas CC. Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15–29 years in the United States, 1999–2017: an ecologic study. Cancer Epidemiol Biomarkers Prev. 2021;30(1):30–37.
- Turbow SD, White MC, Breslau ES, Sabatino SA. Mammography use and breast cancer incidence among older U.S. women. Breast Cancer Res Treat. 2021;188(1):307–316.
2020
- Ellington TD, Henley SJ, Senkomago V, et al. Trends in incidence of cancers of the oral cavity and pharynx—United States, 2007–2016. MMWR Morb Mortal Wkly Rep. 2020;69:433–438.
- Ellington TD, Henley SJ, Wilson RJ, Miller JW. Breast cancer survival among males by race, ethnicity, age, geographic region, and stage—United States, 2007–2016. MMWR Morb Mortal Wkly Rep. 2020;69(41):1481–1484.
- Henley SJ, Peipins LA, Rim SH, Larson TC, Miller JW. Geographic co-occurrence of mesothelioma and ovarian cancer incidence. J Womens Health (Larchmt). 2020;29(1):111–118.
- Iyengar S, Hall IJ, Sabatino SA. Racial/ethnic disparities in prostate cancer incidence, distant stage diagnosis, and mortality by U.S. census region and age-group, 2012–2015. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1357–1364.
- Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race/ethnicity—United States, 2001–2017. MMWR Morb Mortal Wkly Rep. 2020;69:1473–1480.